A Pfizer unit that makes the EpiPen device for Mylan experienced a quality-control meltdown that included a failure to investigate “serious” problems associated with an unspecified number of patient deaths.

Throughout last year, Meridian Medical Technologies received hundreds of complaints that the EpiPen device, which is used to combat serious allergic reactions, failed to operate during life-threatening emergencies. Yet the Pfizer manufacturing unit not only failed to thoroughly investigate the problem, but did not initially remove potentially defective products.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Perhaps the manufacturer didn’t want to count the deaths because then their failures would lead to even more lawsuits.
    Nowadays, when a company says that the harm is not so bad, how do they know it is true?? More likely, they have just closed their eyes & stopped trying to find out the Truth…
    If corporations are people, thanks to SCOTUS, then let their CEOS personally stand trial for murder when their products kill!!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy